Key regions: Brazil, India, Australia, United States, United Kingdom
Antiviral drugs have become increasingly important in the healthcare industry in recent years. Nepal, a small country located in South Asia, has also seen a rise in demand for antiviral drugs.
Customer preferences: The Nepalese population has become more health-conscious in recent years, leading to an increased demand for antiviral drugs. Additionally, the COVID-19 pandemic has further highlighted the importance of antiviral drugs in preventing and treating viral infections.
Trends in the market: The antiviral drug market in Nepal has seen a steady increase in demand in recent years. This can be attributed to the growing prevalence of viral infections such as influenza, hepatitis, and HIV. The market has also seen a shift towards more advanced and effective antiviral drugs, which are more expensive but offer better treatment outcomes.
Local special circumstances: Nepal is a developing country with a relatively low GDP per capita. This means that the majority of the population cannot afford expensive medical treatments, including antiviral drugs. As a result, there is a high demand for affordable antiviral drugs, which has led to the emergence of generic drug manufacturers in Nepal. These manufacturers produce cheaper versions of branded antiviral drugs, making them more accessible to the general population.
Underlying macroeconomic factors: The Nepalese pharmaceutical industry is heavily regulated by the government, which has resulted in a limited number of domestic manufacturers. This has led to a high dependency on imported drugs, including antiviral drugs. The Nepalese government has also implemented policies to promote the local production of generic drugs, which has led to an increase in the number of domestic manufacturers. However, the quality and efficacy of these drugs are often questioned, which has led to a lack of trust among consumers. In conclusion, the antiviral drug market in Nepal is driven by the growing prevalence of viral infections and the increased demand for advanced and effective treatments. The market is also heavily influenced by the local special circumstances, including the high demand for affordable drugs and the limited number of domestic manufacturers. The Nepalese government plays a significant role in regulating the pharmaceutical industry and promoting the local production of drugs.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
